The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer
Abstract
Background: Targeting to integrin receptor α ν β 3 by RGD peptides seems to be a promising approach for gene delivery to proliferating endothelial cells of tumor metastases. PEGylation of cationic polymers offers a reduction of non‐specific binding to cell surfaces. However, little knowledge exists on the influence of charge shielding by PEGylation on targeted gene delivery. Therefore, a variety of RGD peptide‐polyethylenimine (PEI) conjugates with different degrees of substitution, with or without poly(ethylene glycol) (PEG) spacer, were synthesized. Influence of degree of substitution and PEG spacer on physicochemical properties as well as on integrin targeting of DNA/polymer complexes was evaluated. Methods: The tetrapeptide RGDC was coupled to PEI with or without a PEG spacer. Complex formation with DNA was monitored by ethidium bromide (EtBr) fluorescence quenching. Hydrodynamic diameters of complexes and zeta‐potential were assessed using a Zetasizer. Fluorescence correlation spectroscopy (FCS) was used to determine peptide binding to living cells. Transfection efficiency was evaluated employing a luciferase reporter gene. Binding of complexes to Mewo cells was monitored by flow cytometry. Results: Polyplexes of RGD‐PEI or RGD‐PEG‐PEI and DNA showed reduced quenching of EtBr fluorescence compared with PEI. All RGD conjugates formed small polyplexes (approximately 100 nm in diameter at a nitrogen/phosphate (N/P) ratio of 6.7). At N/P = 6.7, the zeta‐potentials of RGD‐PEI complexes were similar to PEI complexes (25–30 mV), while RGD‐PEG‐PEI formed neutral complexes. FCS showed saturable binding of RGD peptide to Mewo human melanoma cells and only low binding to A549 human lung carcinoma cells. A degree of substitution of 4.6% with SPDP as coupling reagent yielded a conjugate showing 50 times higher luciferase expression in Mewo cells than unmodified PEI at low N/P ratios around 3.3, while a degree of substitution of 1.6% only led to a moderately increased transfection efficiency. Flow cytometry experiments suggest that this effect is partly caused by increased attachment of complexes to cell surfaces. No improvement in transfection efficiency was found in α ν β 3‐negative A549 cells. RGD‐PEG‐PEI complexes showed reasonable transfection efficiencies at high N/P ratios; however, no targeting effect could be found. Conclusions: Coupling of the tetrapeptide RGDC without a PEG spacer improved transfection efficiency of PEI in integrin‐expressing Mewo cells by 1–2 orders of magnitude, especially at low N/P ratios. The use of a PEG spacer seems to impair targeting, possibly by not only shielding PEI, but also the RGD ligand. Copyright © 2003 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Algorithm for Least-Squares Estimation of Nonlinear Parameters
Marquardt, D. W. (1963) · Journal of the Society for Industrial and Applied Mathematics · doi:10.1137/0111030 · Cited by 30,728
RGD AND OTHER RECOGNITION SEQUENCES FOR INTEGRINS
Ruoslahti, E. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.697 · Cited by 3,191
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Ogris, M., Brunner, S., Schüller, S., Kircheis, R., & Wagner, E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300900 · Cited by 1,178
Cited by
Nonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 983
Current status of polymeric gene delivery systems☆
PARK, T., JEONG, J., & KIM, S. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.03.007 · Cited by 944
Protein Immobilization Strategies for Protein Biochips
Rusmini, F., Zhong, Z., & Feijen, J. (2007) · Biomacromolecules · doi:10.1021/bm061197b · Cited by 869
Neu, M., Fischer, D., & Kissel, T. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.773 · Cited by 866
Self-citationRecent Advances in Nonviral Vectors for Gene Delivery
Guo, X., & Huang, L. (2012) · Accounts of Chemical Research · doi:10.1021/ar200151m · Cited by 584
A combinatorial polymer library approach yields insight into nonviral gene delivery
Green, J. J., Langer, R., & Anderson, D. G. (2008) · Accounts of Chemical Research · doi:10.1021/ar7002336 · Cited by 579
Functionalized micellar systems for cancer targeted drug delivery
Sutton, D., Nasongkla, N., Blanco, E., & Gao, J. (2007) · Pharmaceutical Research · doi:10.1007/s11095-006-9223-y · Cited by 557
Temming, K., Schiffelers, R. M., Molema, G., & Kok, R. J. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.10.002 · Cited by 467
Dendrimers in Oncology: An Expanding Horizon
Tekade, R. K., Kumar, P. V., & Jain, N. K. (2009) · Chemical Reviews · doi:10.1021/cr068212n · Cited by 466
cRGD‐Functionalized Polymer Micelles for Targeted Doxorubicin Delivery
Nasongkla, N., Shuai, X., Ai, H., Weinberg, B. D., Pink, J., Boothman, D. A., & Gao, J. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200460800 · Cited by 434
Polymer systems for gene delivery—Past, present, and future
Wong, S. Y., Pelet, J. M., & Putnam, D. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.007 · Cited by 427
Li, Z., Zhao, R., Wu, X., Sun, Y., Yao, M., Li, J., Xu, Y., & Gu, J. (2005) · The FASEB Journal · doi:10.1096/fj.05-4058com · Cited by 419
Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery
Wang, F., Wang, Y., Zhang, X., Zhang, W., Guo, S., & Jin, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.020 · Cited by 377
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 363
Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters)
Anderson, D. G., Akinc, A., Hossain, N., & Langer, R. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.015 · Cited by 360
Jäger, M., Schubert, S., Ochrimenko, S., Fischer, D., & Schubert, U. S. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35146c · Cited by 341
Polyethylene Glycol-Conjugated Copolymers for Plasmid DNA Delivery
Lee, M., & Kim, S. W. (2005) · Pharmaceutical Research · doi:10.1007/s11095-004-9003-5 · Cited by 277
Polymeric Materials for Gene Delivery and DNA Vaccination
Nguyen, D. N., Green, J. J., Chan, J. M., Langer, R., & Anderson, D. G. (2009) · Advanced Materials · doi:10.1002/adma.200801478 · Cited by 273
Zhang, Y., Zheng, M., Kissel, T., & Agarwal, S. (2012) · Biomacromolecules · doi:10.1021/bm2015174 · Cited by 60
Self-citation
Metadata
- Authors
- Kunath, K., Merdan, T., Hegener, O., Häberlein, H., & Kissel, T.
- Venue
- The Journal of Gene Medicine
- Publisher
- Wiley
- Published
- 2003-02-20
- Volume
- 5
- Issue
- 7
- Pages
- 588-599
- ISSN
- 1099-498X (ISSN-L)
- 1521-2254
- OpenAlex
- W2080688395
- Cited by
- 231
- References
- 4
- FWCI
- 5.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.